NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.

Don't have an account? Subscribe

Pharma paid almost €7 million to Irish healthcare professionals in 2017

By Mindo - 11th Oct 2018

This compared to €3.8 million paid to named healthcare professionals in 2016 and a further €3.3 million to healthcare professionals who withheld their name for that year’s data.

The details were compiled by the <strong><em>Medical Independent</em></strong> from 44 separate company pages of the IPHA ToV website, which included seven non-IPHA member participating companies.

The total amount given by pharma to healthcare organisations in 2017 was €8.6 million, compared to just over €10 million in 2016.

In terms of funding for research and development, the participants in the IPHA register spent €15.3 million in 2017.

The IPHA ToV register was launched in 2016, with the first published data relating to 2015. Under data protection law, healthcare professionals can withhold their name from publication.

The consent level from healthcare professionals to disclose their name was 58 per cent for the 2017 data, compared to 57 per cent for 2016 and 55 per cent for 2015, according to the IPHA.

Payments to healthcare professionals are described under the category of ‘contribution to costs of events’, which includes sponsorship, registration fees and travel/accommodation; and the category of ‘fee for service and consultancy’, including fees and related expenses.

The IPHA register is part of a voluntary Europe-wide initiative of the European Federation of Pharmaceutical Industries and Associations (EFPIA).

Upon launching the register, the IPHA said it demonstrated “a new level of transparency”.

Leave a Reply

Latest Issue
The Medical Independent 20th February
The Medical Independent 20th February 2024

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read